Serotherapy as Graft-Versus-Host Disease Prophylaxis in Haematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukaemia.

Keogh, Steven J; Dalle, Jean-Hugues; Admiraal, Rick; Pulsipher, Michael A

Keogh, Steven J; Dalle, Jean-Hugues; Admiraal, Rick; Pulsipher, Michael A.

Afiliação

Keogh SJ; Cancer Centre for Children, The Children's Hospital at Westmead, Westmead, NSW, Australia.
Dalle JH; Hôpital Robert Debré, GHU AP-HP. Nord Université de Paris, Paris, France.
Admiraal R; Princess Maxima Center for Pediatric Oncology, University Medical Centre Utrecht, Utrecht, Netherlands.
Pulsipher MA; Children's Hospital Los Angeles, Cancer and Blood Disease Institute, Los Angeles, CA, United States.

Front Pediatr ; 9: 805189, 2021.

Article em En | MEDLINE | ID: mdl-35071142

Palavras-chave

acute lymphoblastic leukaemia; alemtuzumab; anti-T-lymphocyte globulin; anti-thymocyte globulin; graft-versus-host disease (GVHD); haematopoietic stem cell transplant; pharmacokinetics; serotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Pediatr Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google